Nova Eye Valuation
| ELXMF Stock | USD 0 0.00 0.00% |
Nova Eye seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Nova Eye Medical from analyzing the firm fundamentals such as Profit Margin of (0.56) %, current valuation of 25.06 M, and Return On Equity of -0.23 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Nova Eye's price fluctuation is out of control at this time. Calculation of the real value of Nova Eye Medical is based on 3 months time horizon. Increasing Nova Eye's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Nova pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Nova Eye Medical. Since Nova Eye is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nova Pink Sheet. However, Nova Eye's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0019 | Real 0.001824 | Hype 0.001158 |
The real value of Nova Pink Sheet, also known as its intrinsic value, is the underlying worth of Nova Eye Medical Company, which is reflected in its stock price. It is based on Nova Eye's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Nova Eye's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Nova Eye Medical helps investors to forecast how Nova pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nova Eye more accurately as focusing exclusively on Nova Eye's fundamentals will not take into account other important factors: About Nova Eye Valuation
The pink sheet valuation mechanism determines Nova Eye's current worth on a weekly basis. Our valuation model uses a comparative analysis of Nova Eye. We calculate exposure to Nova Eye's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nova Eye's related companies.Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. Nova Eye Medical Limited was founded in 1985 and is headquartered in Kent Town, Australia. Nova Eye operates under Medical Devices classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Nova Eye's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Nova Eye's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Nova Eye's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Nova Eye's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Nova Eye's revenue streams: Identify Nova Eye's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Nova Eye's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Nova Eye's growth potential: Evaluate Nova Eye's management, business model, and growth potential.
- Determine Nova Eye's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Nova Eye's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Nova Eye Growth Indicators
Investing in growth stocks can be very risky. If the company such as Nova Eye does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 145.6 M | |
| Forward Price Earnings | 80.6452 | |
| Retained Earnings | -6.6 M | |
| Shares Float | 110.6 M |
Complementary Tools for Nova Pink Sheet analysis
When running Nova Eye's price analysis, check to measure Nova Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Eye is operating at the current time. Most of Nova Eye's value examination focuses on studying past and present price action to predict the probability of Nova Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Eye's price. Additionally, you may evaluate how the addition of Nova Eye to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |